The synthetic hallucinogen, 2C-B, that has been offered in Latin American and Caribbean regions as “cocaina rosada” could potentially cause a range of unwanted outcomes.Medicines marketed as “pink copyright” could include any quantity of medicines and additives capable of producing gentle to severe outcomes on well being.The retailer also o